• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

First patient treated with CSA Medical’s AV spray catheter

October 3, 2017 By Sarah Faulkner

CSA MedicalCSA Medical said today that the first patient was treated using the company’s new rapid AV spray catheter for the management of persistent symptomatic esophageal cancer and associated dysplastic Barrett’s disease.

The device uses a stainless steel catheter wall to cut the time needed to deliver liquid nitrogen spray to the treatment site by 50%, the company said. It was recently cleared for use with CSA Medical’s truFreeze system – a cryosurgical tool used to ablate benign and malignant lesions.

The first patient was treated at the University of Rochester Medical Center by Dr. Vivek Kaul, the company noted.

“With a significantly reduced time to ‘spray actuation’ and a uniform, non-dissipating freeze pattern, we found the Rapid AV catheter to work reliably, consistently and effectively in a diverse array of clinical settings, from flat Barrett’s ablation to bulky tumor palliation,” Kaul said in prepared remarks.

“This product expansion solidifies truFreeze liquid nitrogen spray cryotherapy as the only ablation solution for the full range of Barrett’s Esophagus disease as well as esophageal cancer,” president & CEO Dr. Ellen Sheets added.

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Oncology Tagged With: csamedical

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS